Cytokinetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CEORobert I. Blum
CEORobert I. Blum
Employees498
Employees498
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded1997
Founded1997
Employees498
Employees498
CYTK Key Statistics
Market cap4.02B
Market cap4.02B
Price-Earnings ratio-6.34
Price-Earnings ratio-6.34
Dividend yield—
Dividend yield—
Average volume1.45M
Average volume1.45M
High today$34.38
High today$34.38
Low today$32.55
Low today$32.55
Open price$32.94
Open price$32.94
Volume1.02M
Volume1.02M
52 Week high$61.38
52 Week high$61.38
52 Week low$29.31
52 Week low$29.31
Analyst ratings
86%
of 22 ratingsBuy
86.4%
Hold
13.6%
Sell
0%
People also own
Based on the portfolios of people who own CYTK. This list is generated using Robinhood data, and it’s not a recommendation.